
veins surgery,117 no beneﬁt was noted.
In a nonrandomized, controlled multicenter prospective study (DEFANCE trial),118 245 C2 patients underwent
HL&S combined with stab avulsion. Patients in one group
(n ¼ 200) received 1000 mg of MPFF daily, the control
group (n ¼ 45) had no drug treatment. Compression
(class 2) was